Professor

Andrew Clouston

Email: 

Availability

Professor Andrew Clouston is:
Available for supervision

Fields of research

Clinical sciences Oncology and carcinogenesis

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia

Search Professor Andrew Clouston’s works on UQ eSpace

391 works between 1993 and 2026
All (391) Journal Article (222) Other Outputs (1) Conference Publication (160) Book Chapter (8)

101 - 120 of 391 works

2016

Conference Publication

IL-28 Is a critical cytoprotectant in transplantation

Henden, A., Robb, R., Clouston, A., Kuns, R., Lane, S., Gartlan, K. and Hill, G. (2016). IL-28 Is a critical cytoprotectant in transplantation. International Congress of Immunology (ICI), Melbourne, Australia, 21-26 August 2016. Weinheim, Germany: Wiley-VCH.

IL-28 Is a critical cytoprotectant in transplantation

2016

Journal Article

Point mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant

Li, Jun, Woods, Susan L., Healey, Sue, Beesley, Jonathan, Chen, Xiaoqing, Lee, Jason S., Sivakumaran, Haran, Wayte, Nicci, Nones, Katia, Waterfall, Joshua J., Pearson, John, Patch, Anne-Marie, Senz, Janine, Ferreira, Manuel A., Kaurah, Pardeep, Mackenzie, Robertson, Heravi-Moussavi, Alireza, Hansford, Samantha, Lannagan, Tamsin R. M., Spurdle, Amanda B., Simpson, Peter T., da Silva, Leonard, Lakhani, Sunil R., Clouston, Andrew D., Bettington, Mark, Grimpen, Florian, Busuttil, Rita A., Di Costanzo, Natasha, Boussioutas, Alex ... Chenevix-Trench, Georgia (2016). Point mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. American Journal of Human Genetics, 98 (5), 830-842. doi: 10.1016/j.ajhg.2016.03.001

Point mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant

2016

Conference Publication

Autophagy-dependent TIGIT+ Treg are critical for the maintenance of tolerance

MacDonald, Kelli P. A., Le Texier, Laetitia, Leveque-ElMouttie, Lucie, Lineburg, Katie, Nicholls, Jemma, Guimaraes, Fernando Souza-Fonseca, Alexander, Kylie, Clouston, Andrew, Blazar, Bruce R. and Hill, Geoff R. (2016). Autophagy-dependent TIGIT+ Treg are critical for the maintenance of tolerance. Immunology 2016 Meeting, Seattle, WA United States, 13-17 May 2016. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.196.supp.125.14

Autophagy-dependent TIGIT+ Treg are critical for the maintenance of tolerance

2016

Journal Article

Serrated tubulovillous adenoma of the large intestine

Bettington, Mark, Walker, Neal, Rosty, Christophe, Brown, Ian, Clouston, Andrew, Mckeone, Diane, Pearson, Sally-Ann, Klein, Kerenaftali, Leggett, Barbara and Whitehall, Vicki (2016). Serrated tubulovillous adenoma of the large intestine. Histopathology, 68 (4), 578-587. doi: 10.1111/his.12788

Serrated tubulovillous adenoma of the large intestine

2016

Journal Article

Spatiotemporal characterization of the cellular and molecular contributors to liver fibrosis in a murine hepatotoxic-injury model

Melino, Michelle, Gadd, Victoria L., Alexander, Kylie A., Beattie, Lynette, Lineburg, Katie E., Martinez, Michelle, Teal, Bianca, Le Texier, Laetitia, Irvine, Katharine M., Miller, Gregory C., Boyle, Glen M., Hill, Geoffrey R., Clouston, Andrew D., Powel, Elizabeth E. and MacDonald, Kelli P. A. (2016). Spatiotemporal characterization of the cellular and molecular contributors to liver fibrosis in a murine hepatotoxic-injury model. American Journal of Pathology, 186 (3), 524-538. doi: 10.1016/j.ajpath.2015.10.029

Spatiotemporal characterization of the cellular and molecular contributors to liver fibrosis in a murine hepatotoxic-injury model

2016

Conference Publication

Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes

Patel, P. J., Stuart, K. A., Horsfall, L. U., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Clouston, A., Irvine, K. M., Russell, A. and Powell, E. E. (2016). Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, SA, Australia, 10-12 October 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13520

Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes

2015

Journal Article

Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

Leung, Daniel H., Khan, Mahjabeen, Minard, Charles G., Guffey, Danielle, Ramm, Louise E., Clouston, Andrew D., Miller, Gregory, Lewindon, Peter J., Shepherd, Ross W. and Ramm, Grant A. (2015). Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology, 62 (5), 1576-1583. doi: 10.1002/hep.28016

Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

2015

Journal Article

Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury

Irvine, Katharine M., Clouston, Andrew D., Gadd, Victoria L., Miller, Gregory C., Wong, Weng-Yew, Melino, Michelle, Maradana, Muralidhara Rao, MacDonald, Kelli, Lang, Richard A., Sweet, Matthew J., Blumenthal, Antje and Powell, Elizabeth E. (2015). Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogenesis and Tissue Repair, 8 (19) 19, 19. doi: 10.1186/s13069-015-0036-7

Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury

2015

Journal Article

Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial

Stevenson, Andrew R. L., Solomon, Michael J., Lumley, John W., Hewett, Peter, Clouston, Andrew D., Gebski, Val J., Davies, Lucy, Wilson, Kate, Hague, Wendy and Simes, John (2015). Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA - Journal of the American Medical Association, 314 (13), 1356-1363. doi: 10.1001/jama.2015.12009

Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial

2015

Journal Article

Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8<sup>+</sup> T cells that induce GVHD without antileukemic effects

Gartlan, Kate H., Markey, Kate A., Varelias, Antiopi, Bunting, Mark D., Koyama, Motoko, Kuns, Rachel D., Raffelt, Neil C., Olver, Stuart D., Lineburg, Katie E., Cheong, Melody, Teal, Bianca E., Lor, Mary, Comerford, Iain, Teng, Michele W. L., Smyth, Mark J., McCluskey, James, Rossjohn, Jamie, Stockinger, Brigitta, Boyle, Glen M., Lane, Steven W., Clouston, Andrew D., McColl, Shaun R., MacDonald, Kelli P. A. and Hill, Geoffrey R. (2015). Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects. Blood, 126 (13), 1609-1620. doi: 10.1182/blood-2015-01-622662

Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8<sup>+</sup> T cells that induce GVHD without antileukemic effects

2015

Journal Article

Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice

Wikstrom, Matthew E., Fleming, Peter, Kuns, Rachel D., Schuster, Iona S., Voigt, Valentina, Miller, Gregory, Clouston, Andrew D., Tey, Siok-Keen, Andoniou, Christopher E., Hill, Geoffrey R. and Degli-Esposti, Mariapia A. (2015). Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice. Blood, 126 (12), 1503-1514. doi: 10.1182/blood-2015-01-622837

Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice

2015

Conference Publication

Idelalisib-induced acute proctocolitis: clinical and histological findings

Hendy, P., Rosty, C., Bashford, J., Clouston, A. and Burger, D. (2015). Idelalisib-induced acute proctocolitis: clinical and histological findings. Gastro 2015 GESA‐AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015, Brisbane, QLD, Australia, 28 September‐2 October 2015. Hoboken, NJ, United States: Wiley-Blackwell Publishing. doi: 10.1111/jgh.13094

Idelalisib-induced acute proctocolitis: clinical and histological findings

2015

Journal Article

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

Irvine, Katharine M., Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin J., Horsfall, Leigh U., Fletcher, Linda M., Ungerer, Jacobus P. J., Pretorius, Carel J., Miller, Gregory C., Clouston, Andrew D., Lampe, Guy and Powell, Elizabeth E. (2015). The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver International, 36 (3), 370-377. doi: 10.1111/liv.12896

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

2015

Journal Article

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

Fagan, Kevin J., Pretorius, Carel J., Horsfall, Leigh U., Irvine, Katharine M., Wilgen, Urs, Choi, Kihoon, Fletcher, Linda M., Tate, Jill, Melino, Michelle, Nusrat, Sharmin, Miller, Gregory C., Clouston, Andrew D., Ballard, Emma, O'Rourke, Peter, Lampe, Guy, Ungerer, Jacobus P. J. and Powell, Elizabeth E. (2015). ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. Liver International, 35 (6), 1673-1681. doi: 10.1111/liv.12760

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

2015

Journal Article

Effect of resveratrol on experimental non-alcoholic steatohepatitis

Heeboll, Sara, Thomsen, Karen Louise, Clouston, Andrew, Sundelin, Elias Immanuel, Radko, Yulia, Christensen, Lars Porskjaer, Ramezani-Moghadam, Mehdi, Kreutzfeldt, Martin, Pedersen, Steen Bonlokke, Jessen, Niels, Hebbard, Lionel, George, Jacob and Gronbaek, Henning (2015). Effect of resveratrol on experimental non-alcoholic steatohepatitis. Pharmacological Research, 95-96, 34-41. doi: 10.1016/j.phrs.2015.03.005

Effect of resveratrol on experimental non-alcoholic steatohepatitis

2015

Journal Article

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma

Whiteman, David C., Appleyard, Mark, Bahin, Farzan F., Bobryshev, Yuri V., Bourke, Michael J., Brown, Ian, Chung, Adrian, Clouston, Andrew, Dickins, Emma, Emery, Jon, Eslick, Guy D., Gordon, Louisa G., Grimpen, Florian, Hebbard, Geoff, Holliday, Laura, Hourigan, Luke F., Kendall, Bradley J., Lee, Eric Y. T., Levert-Mignon A., Lord, Reginald V., Lord, Sarah J., Maule, Derek, Moss, Alan, Norton, Ian, Olver, Ian, Pavey, Darren, Raftopoulos, Spiro, Rajendra, Shan, Schoeman, Mark ... Yusoff, Ian F. (2015). Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology (Australia), 30 (5), 804-820. doi: 10.1111/jgh.12913

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma

2015

Journal Article

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation

Varelias, Antiopi, Gartlan, Kate H., Kreijveld, Ellen, Olver, Stuart D., Lor, Mary, Kuns, Rachel D., Lineburg, Katie E., Teal, Bianca E., Raffelt, Neil C., Cheong, Melody, Alexander, Kylie A., Koyama, Motoko, Markey, Kate A., Sturgeon, Elise, Leach, Justine, Reddy, Pavan, Kennedy, Glen A., Yanik, Gregory A., Blazar, Bruce R., Tey, Siok-Keen, Clouston, Andrew D., MacDonald, Kelli P. A., Cooke, Kenneth R. and Hill, Geoffrey R. (2015). Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood, 125 (15), 2435-2444. doi: 10.1182/blood-2014-07-590232

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation

2015

Journal Article

Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice

Bridle, Kim R., Sobbe, Amy L., de Guzman, C. Erika, Santrampurwala, Nishreen, Jaskowski, Lesley A., Clouston, Andrew D., Campbell, Catherine M., Nathan Subramaniam, V. and Crawford, Darrell H. G. (2015). Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice. Liver International, 35 (4), 1451-1463. doi: 10.1111/liv.12494

Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2-/- mice

2015

Conference Publication

EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS

Heeboll, S., Thomsen, K. L., Clouston, A., Jessen, N., Sundelin, E. I., Pedersen, S. B., Radko, Y., Christensen, L. P., Hebbard, L., Gronbaek, H. and George, J. (2015). EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS. 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna Austria, Apr 22-26, 2015. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(15)31175-2

EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS

2015

Journal Article

Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply

Bedossa, Charles, Burt, Alastair D, Brunt, Elizabeth, Callea, Francesco, Clouston, Andrew D, Dienes, Hans Peter, Goodman, Zachary D, Gouw, Annette S. H, Hubscher, Stefan G, Roberts, Eve A, Roskams, Tania, Terracciano, Luigi, Tiniakos, Dina G, Torbenson, Michael S and Wanless, Ian R (2015). Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply. Human Pathology, 46 (4), 635-636. doi: 10.1016/j.humpath.2014.10.030

Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply

Current funding

  • 2026 - 2029
    Targeting the ageing liver transcription factor network to prevent and treat MASLD
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2019 - 2022
    CSF1 Therapy for Chronic Liver Disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2019
    A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial. A phase III prospective randomised trial comparing laparoscopic-assisted ... (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2016
    Identifying Protective v Pathogenic Macrophages in Chronic Liver Disease: Critical for Macrophage-Targeted Therapy
    PA Research Foundation
    Open grant
  • 2013 - 2014
    Targeting the Wnt Pathway: Implication for Chronic Liver disease
    PA Research Foundation
    Open grant
  • 2013 - 2015
    Defining the role of MMP-9-expressing macrophages in liver injury in chronic liver disease
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Monocytes/macrophages in chronic liver diseases: cross-talk with hepatocytes and nonparenchymal cells and role in progressive liver injury
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies
    NHMRC Project Grant
    Open grant
  • 2007 - 2009
    Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis
    NHMRC Project Grant
    Open grant
  • 2006 - 2009
    The Role Of Hepatic Progenitor Cells And A Ductular Reaction In Disease Progression In Non-Alcoholic Fatty Liver Disease
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005
    The effect of obesity on liver function in children who are long term liver transplant recipients
    Royal Children's Hospital Foundation
    Open grant
  • 2005 - 2007
    The role of steatosis in promoting cellular injury and fibrogenesis in human liver disease
    NHMRC Project Grant
    Open grant
  • 2004 - 2005
    The Effect Of Alcohol On Hepatitis C-Induced Liver Disease
    Australian Brewers' Foundation
    Open grant
  • 2002 - 2004
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    NHMRC Project Grant
    Open grant
  • 2002
    Strategies to monitor graft acceptance following human liver transplantation
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001 - 2002
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Mayne Bequest Fund
    Open grant
  • 2001
    Fibrosis after liver transplantation - role of the renin angiotensin system
    Royal Children's Hospital Foundation
    Open grant
  • 2001
    Hepatitis C virus and the host: Viral effects on lipid metabolism and fibrogenesis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2000
    Investigation of the relationship between steatosis, lipid peroxidation and fibrosis in chronic hepatitis C
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1999
    Donor leucocytes contribute to liver allograft acceptance: investigation of a mechanism
    Royal Children's Hospital Foundation
    Open grant
  • 1999
    Fine needle aspiration of liver grafts to monitor apoptosis of graft infiltrating leucocytes
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1998
    Cytokine modulation ofliver associated leucocyte proliferation and cytotoxicity
    Royal Children's Hospital
    Open grant
  • 1997
    Characterisation of leucocytes derived from human liver preservation perfusate: a new form of donor-specific transfusion?
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1997
    Frequency and distribution of cytokine expression in liver allograft rejection
    University of Queensland New Staff Research Grant
    Open grant
  • 1997
    Mechanisms by which liver-derived leucocytes may promote human graft acceptance
    Royal Children's Hospital Foundation
    Open grant
  • 1996
    Characterization of chimeric leucocytes following human liver transplantation
    Mayne Bequest Fund
    Open grant

Availability

Professor Andrew Clouston is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Professor Andrew Clouston's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au